Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney diseaseLaTonya J. Hickson, James L. Kirkland, Nino Giorgadze et al.|EBioMedicine|2019Cited by 1.3k
Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456LaTonya J. Hickson, James L. Kirkland, Larissa Prata et al.|EBioMedicine|2020Cited by 59